These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 34132188)

  • 1. Hypothesis: Designation of Liposomal Scavenger System for Fight against
    Bagherani N; Smoller BR
    Infect Disord Drug Targets; 2022; 22(1):e150621194093. PubMed ID: 34132188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human and novel coronavirus infections in children: a review.
    Rajapakse N; Dixit D
    Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent Patents and Advances on Nanotechnologies against Coronavirus.
    Abedini-Nassab R; Mahdaviyan N
    Recent Pat Nanotechnol; 2021; 15(4):322-330. PubMed ID: 33172382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutralizing and binding activities against SARS-CoV-1/2, MERS-CoV, and human coronaviruses 229E and OC43 by normal human intravenous immunoglobulin derived from healthy donors in Japan.
    Kubota-Koketsu R; Terada Y; Yunoki M; Sasaki T; Nakayama EE; Kamitani W; Shioda T
    Transfusion; 2021 Feb; 61(2):356-360. PubMed ID: 33104267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microneedle array delivered recombinant coronavirus vaccines: Immunogenicity and rapid translational development.
    Kim E; Erdos G; Huang S; Kenniston TW; Balmert SC; Carey CD; Raj VS; Epperly MW; Klimstra WB; Haagmans BL; Korkmaz E; Falo LD; Gambotto A
    EBioMedicine; 2020 May; 55():102743. PubMed ID: 32249203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An overview on the seven pathogenic human coronaviruses.
    Kesheh MM; Hosseini P; Soltani S; Zandi M
    Rev Med Virol; 2022 Mar; 32(2):e2282. PubMed ID: 34339073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The durability of immunity against reinfection by SARS-CoV-2: a comparative evolutionary study.
    Townsend JP; Hassler HB; Wang Z; Miura S; Singh J; Kumar S; Ruddle NH; Galvani AP; Dornburg A
    Lancet Microbe; 2021 Dec; 2(12):e666-e675. PubMed ID: 34632431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19: A Worldwide, Zoonotic, Pandemic Outbreak.
    Khan T; Agnihotri K; Tripathi A; Mukherjee S; Agnihotri N; Gupta G
    Altern Ther Health Med; 2020 Aug; 26(S2):56-64. PubMed ID: 32412918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19: a conundrum to decipher.
    Deshmukh V; Tripathi SC; Pandey A; Deshmukh V; Vykoukal J; Patil A; Sontakke B
    Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5830-5841. PubMed ID: 32495923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fully automated detection and differentiation of pandemic and endemic coronaviruses (NL63, 229E, HKU1, OC43 and SARS-CoV-2) on the hologic panther fusion.
    Cordes AK; Rehrauer WM; Accola MA; Wölk B; Hilfrich B; Heim A
    J Med Virol; 2021 Jul; 93(7):4438-4445. PubMed ID: 33350484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Spectrum of COVID-19 Cases and their Correlation with S.LDH Levels- An Observational Study from Southeast Rajasthan.
    Gupta D; Sharma R; Patwardhan B; Mathur RD
    J Assoc Physicians India; 2021 Sep; 69(9):11-12. PubMed ID: 34585882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-Coronavirus Vaccines: Past Investigations on SARS-CoV-1 and MERS-CoV, the Approved Vaccines from BioNTech/Pfizer, Moderna, Oxford/AstraZeneca and others under Development Against SARSCoV- 2 Infection.
    Costanzo M; De Giglio MAR; Roviello GN
    Curr Med Chem; 2022; 29(1):4-18. PubMed ID: 34355678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 Infection: Epidemiology, Virology, Clinical Features, Diagnosis and Pharmacological Treatment.
    Kaur A; Bhalla V; Salahuddin M; Rahman SO; Pottoo FH
    Curr Pharm Des; 2021; 27(33):3551-3565. PubMed ID: 33430745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel coronavirus 2019-nCoV: prevalence, biological and clinical characteristics comparison with SARS-CoV and MERS-CoV.
    Meo SA; Alhowikan AM; Al-Khlaiwi T; Meo IM; Halepoto DM; Iqbal M; Usmani AM; Hajjar W; Ahmed N
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):2012-2019. PubMed ID: 32141570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Replication of Severe Acute Respiratory Syndrome Coronavirus 2 in Human Respiratory Epithelium.
    Milewska A; Kula-Pacurar A; Wadas J; Suder A; Szczepanski A; Dabrowska A; Owczarek K; Marcello A; Ochman M; Stacel T; Rajfur Z; Sanak M; Labaj P; Branicki W; Pyrc K
    J Virol; 2020 Jul; 94(15):. PubMed ID: 32434888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Case Study: Analysis of Patents on Coronaviruses and Covid-19 for Technological Assessment and Future Research.
    Musyuni P; Aggarwal G; Nagpal M; Goyal RK
    Curr Pharm Des; 2021; 27(3):423-439. PubMed ID: 32693757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Properties of Coronavirus and SARS-CoV-2.
    Malik YA
    Malays J Pathol; 2020 Apr; 42(1):3-11. PubMed ID: 32342926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
    Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
    J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronaviruses - a new old menace.
    Golke A; Piekarska K; Dzieciątkowski T
    Postepy Biochem; 2020 Dec; 66(4):303-308. PubMed ID: 33470077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coronavirus diseases and pregnancy: COVID-19,SARS, and MERS.
    Fathi M; Vakili K; Deravi N; Yaghoobpoor S; Ahsan E; Mokhtari M; Moshfeghi M; Vaezjalali M
    Przegl Epidemiol; 2020; 74(2):276-289. PubMed ID: 33112124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.